# Buprenorphine to Improve HIV Care Engagement and Outcomes

> **NCT01936857** · PHASE4 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 281 (actual)

## Conditions studied

- HIV
- Substance Related Disorders

## Interventions

- **DRUG:** Buprenorphine/naloxone
- **DRUG:** Methadone Maintenance Therapy

## Key facts

- **NCT ID:** NCT01936857
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2019-03
- **Final completion:** 2019-04
- **Target enrollment:** 281 (ACTUAL)
- **Last updated:** 2022-05-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01936857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01936857, "Buprenorphine to Improve HIV Care Engagement and Outcomes". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01936857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*